Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box

Overview

Journal Stem Cells Int

Publisher Wiley

Specialty Cell Biology

Date 2011 Aug 2

PMID 21804827

Citations 9

Authors

V K Shah

K K Shalia

Affiliations

Soon will be listed here.

Abstract

Stem cell therapy for conditions characterized by myocyte loss in myocardial infarction and heart failure is intuitively appealing. Stem cells from various sources, including heart itself in preclinical and animal studies, have shown the potential to improve the function of ventricular muscle after ischaemic injury. The clinical experience from worldwide studies have indicated the safety profile but with modest benefits. The predominant mechanisms of transplanted cells for improving cardiac function have pointed towards paracrine effects rather than transdifferentiation into cardiomyocytes. Thus, further investigations should be encouraged towards bench side and bedside to resolve various issues for ensuring the correct type and dosing of cells, time, and method of delivery and identify correct mechanism of functional improvement. An interdisciplinary effort at the scientific, clinical, and the government front will bring successful realization of this therapy for healing the heart and may convert what seems now a Pandora's Box into a Pot of Gold.

Citing Articles

Role of apoptotic inhibitors, viability, and differentiation in low oxygen tension of mesenchymal stem cells cultured in a rat model of ovarian failure.

Safitri E, Purnobasuki H, Purnama M, Chhetri S F1000Res. 2024; 12:24.

PMID: 38644927 PMC: 11031646. DOI: 10.12688/f1000research.124919.1.

Beneficial Effects of Angiotensin-(1-7) on CD34+ Cells From Patients With Heart Failure.

Cole-Jeffrey C, Pepine C, Katovich M, Grant M, Raizada M, Hazra S J Cardiovasc Pharmacol. 2017; 71(3):155-159.

PMID: 29140957 PMC: 5839943. DOI: 10.1097/FJC.0000000000000556.

Efficacy of stem cell in improvement of left ventricular function in acute myocardial infarction--MI3 Trial.

Nair V, Madan H, Sofat S, Ganguli P, Jacob M, Datta R Indian J Med Res. 2015; 142(2):165-74.

PMID: 26354213 PMC: 4613437. DOI: 10.4103/0971-5916.164245.

Acute myocardial infarction does not affect functional characteristics of adipose-derived stem cells in rats, but reduces the number of stem cells in adipose tissue.

Naaijkens B, Krijnen P, Meinster E, Ter Horst E, Vo K, Musters R Cell Tissue Res. 2015; 362(3):623-32.

PMID: 26202892 PMC: 4675794. DOI: 10.1007/s00441-015-2239-z.

Exogenous connexin43-expressing autologous skeletal myoblasts ameliorate mechanical function and electrical activity of the rabbit heart after experimental infarction.

Antanaviciute I, Ereminiene E, Vysockas V, Rackauskas M, Skipskis V, Rysevaite K Int J Exp Pathol. 2014; 96(1):42-53.

PMID: 25529770 PMC: 4352351. DOI: 10.1111/iep.12109.

References

Erbs S, Linke A, Adams V, Lenk K, Thiele H, Diederich K . Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res. 2005; 97(8):756-62. DOI: 10.1161/01.RES.0000185811.71306.8b. View

Bittira B, Shum-Tim D, Al-Khaldi A, Chiu R . Mobilization and homing of bone marrow stromal cells in myocardial infarction. Eur J Cardiothorac Surg. 2003; 24(3):393-8. DOI: 10.1016/s1010-7940(03)00325-7. View

Moore K, Lemischka I . Stem cells and their niches. Science. 2006; 311(5769):1880-5. DOI: 10.1126/science.1110542. View

Wang Y, Johnsen H, Mortensen S, Bindslev L, Ripa R, Haack-Sorensen M . Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart. 2005; 92(6):768-74. PMC: 1860647. DOI: 10.1136/hrt.2005.069799. View

Erices A, Conget P, Minguell J . Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000; 109(1):235-42. DOI: 10.1046/j.1365-2141.2000.01986.x. View

Okita K, Ichisaka T, Yamanaka S . Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448(7151):313-7. DOI: 10.1038/nature05934. View

Martin C, Meeson A, Robertson S, Hawke T, Richardson J, Bates S . Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol. 2003; 265(1):262-75. DOI: 10.1016/j.ydbio.2003.09.028. View

Hare J, Traverse J, Henry T, Dib N, Strumpf R, Schulman S . A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009; 54(24):2277-86. PMC: 3580848. DOI: 10.1016/j.jacc.2009.06.055. View

Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A . Human cardiac stem cells. Proc Natl Acad Sci U S A. 2007; 104(35):14068-73. PMC: 1955818. DOI: 10.1073/pnas.0706760104. View

10.

Jackson K, Majka S, Wang H, Pocius J, Hartley C, Majesky M . Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001; 107(11):1395-402. PMC: 209322. DOI: 10.1172/JCI12150. View

11.

Liu X, Pachori A, Ward C, Davis J, Gnecchi M, Kong D . Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function. FASEB J. 2006; 20(2):207-16. DOI: 10.1096/fj.05-4435com. View

12.

Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F . Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004; 95(9):911-21. DOI: 10.1161/01.RES.0000147315.71699.51. View

13.

Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Matsuoka S . Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation. 2008; 118(5):498-506. DOI: 10.1161/CIRCULATIONAHA.108.769562. View

14.

Spangrude G, Heimfeld S, Weissman I . Purification and characterization of mouse hematopoietic stem cells. Science. 1988; 241(4861):58-62. DOI: 10.1126/science.2898810. View

15.

Ripa R, Jorgensen E, Wang Y, Thune J, Nilsson J, Sondergaard L . Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial.... Circulation. 2006; 113(16):1983-92. DOI: 10.1161/CIRCULATIONAHA.105.610469. View

16.

Toma C, Pittenger M, Cahill K, Byrne B, Kessler P . Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002; 105(1):93-8. DOI: 10.1161/hc0102.101442. View

17.

Hahn J, Cho H, Kang H, Kim T, Kim M, Chung J . Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol. 2008; 51(9):933-43. DOI: 10.1016/j.jacc.2007.11.040. View

18.

Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R . Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001; 104(9):1046-52. DOI: 10.1161/hc3501.093817. View

19.

Behfar A, Zingman L, Hodgson D, Rauzier J, Kane G, Terzic A . Stem cell differentiation requires a paracrine pathway in the heart. FASEB J. 2002; 16(12):1558-66. DOI: 10.1096/fj.02-0072com. View

20.

Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson S, Li B . Bone marrow cells regenerate infarcted myocardium. Nature. 2001; 410(6829):701-5. DOI: 10.1038/35070587. View